Introduction
The global schizophrenia drugs market is poised to grow from USD 7.4 billion in 2022 to USD 12.6 billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032. Schizophrenia, a severe mental disorder, typically emerges in late adolescence or early adulthood, marked by symptoms such…
[ad_2]
Source link
